Cargando…
Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB-152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway
Acute lymphoblastic leukemia (ALL) is a malignant hematological disease. Tanshinone IIA (Tan IIA) has antitumor activity in vitro and in vivo. The aim of the present study was to investigate the effects of Tan IIA in combination with imatinib (IM) on the proliferation, apoptosis, migration and invas...
Autores principales: | Teng, Zhi, Xu, Shijuan, Lei, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967082/ https://www.ncbi.nlm.nih.gov/pubmed/31894340 http://dx.doi.org/10.3892/or.2019.7453 |
Ejemplares similares
-
Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway
por: Liu, Huayuan, et al.
Publicado: (2021) -
Tanshinone IIa Induces Autophagy and Apoptosis via PI3K/Akt/mTOR Axis in Acute Promyelocytic Leukemia NB4 Cells
por: Pan, Yiming, et al.
Publicado: (2021) -
Tanshinone IIA induces autophagy in colon cancer cells through MEK/ERK/mTOR pathway
por: Qian, Jun, et al.
Publicado: (2020) -
Inhibitory Effect of Tanshinone IIA on Rat Hepatic Stellate Cells
por: Liu, Ya-Wei, et al.
Publicado: (2014) -
Tanshinone IIA potentiates the efficacy of imatinib by regulating the AKT-MDM2-P53 signaling pathway in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Guo, Yong, et al.
Publicado: (2022)